Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AN15368
Therapeutic Area : Infections and Infectious Diseases
Study Phase : IND Enabling
Sponsor : AN2 Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : The agreement aims to advance the development of AN2-502998 (formerly known as AN15368), a boron-based small molecule therapeutic under development for the treatment of Chagas disease.
Brand Name : AN2-502998
Molecule Type : Small molecule
Upfront Cash : Undisclosed
October 18, 2023
Lead Product(s) : AN15368
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : IND Enabling
Sponsor : AN2 Therapeutics
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?